Guggenheim Maintains Buy on Exelixis, Raises Price Target to $33

Exelixis, Inc. +0.82%

Exelixis, Inc.

EXEL

35.80

+0.82%

Guggenheim analyst Michael Schmidt maintains Exelixis (NASDAQ: EXEL) with a Buy and raises the price target from $32 to $33.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via